Cross-sectional price momentum — buying stocks that went up the most — is the strongest standalone factor we tested. We compare four academic momentum variants (Jegadeesh-Titman 12-1, 6-1, 12-2, and Novy-Marx intermediate) across three market cap levels. Then we add value exclusion filters and an MA200 regime overlay to see how far we can push it.
All strategies: buy the top 25 stocks by momentum, equal weight, hold until next rebalance. No sector exclusions (momentum is purely price-based). Universe refreshed annually from Sharadar fundamentals for market cap filter.
| Strategy | >$200M | >$1B | >$5B | ||||||
|---|---|---|---|---|---|---|---|---|---|
| CAGR | Sharpe | DD | CAGR | Sharpe | DD | CAGR | Sharpe | DD | |
| Mom 12-1 | +5.6% | 0.33 | -67.8% | +12.4% | 0.55 | -68.6% | +13.0% | 0.61 | -64.3% |
| Mom 6-1 | +10.8% | 0.55 | -68.6% | +13.0% | 0.55 | -68.6% | +13.5% | 0.68 | -64.3% |
| Mom 12-2 | +4.8% | 0.33 | -67.8% | +13.0% | 0.55 | -68.6% | +12.2% | 0.58 | -64.3% |
| Interm (7-12) | -4.5% | 0.05 | -81.4% | +8.9% | 0.43 | -67.7% | +11.1% | 0.55 | -60.3% |
| S&P 500 | ~+8.4% CAGR · Sharpe ~0.61 | ||||||||
Market cap is the single most important filter. At >$200M, all momentum strategies except Mom 6-1 fail. At >$5B, all four beat the S&P. Small-cap "momentum" stocks include pump-and-dumps, lottery tickets, and penny stocks that spike temporarily. Large-cap momentum is cleaner — driven by genuine earnings growth and institutional flows.
| Strategy | >$200M | >$1B | >$5B |
|---|---|---|---|
| Mom 12-1 | +4.8% | +10.8% | +12.1% |
| Mom 6-1 | +6.2% | +10.3% | +11.7% |
| Mom 12-2 | +4.8% | +10.8% | +12.2% |
| Interm (7-12) | +3.1% | +7.9% | +10.2% |
| S&P 500 | ~+8.4% CAGR | ||
Monthly rebalance outperforms annual by +1–2% at >$5B. The difference is larger at smaller market caps because fresh momentum signals matter more when the universe includes volatile small stocks. At >$5B, annual rebalance is nearly as effective — large-cap momentum trends persist longer.
Instead of combining value and momentum into a composite (like Trending Value), we take the opposite approach: use momentum as the primary signal but exclude stocks from the worst value deciles. This removes the most overvalued momentum stocks — the ones most likely to be speculative bubbles.
| Strategy (>$5B) | CAGR | Sharpe | Max DD |
|---|---|---|---|
| Pure Mom (10) | +17.1% | 0.70 | -59.2% |
| Excl top P/S (10) | +18.1% | 0.78 | -57.0% |
| Excl P/S+SY (10) | +16.7% | 0.76 | -58.5% |
| Excl ALL+MA200 (10) | +14.0% | 0.81 | -29.6% |
| Pure Mom (25) | +13.5% | 0.68 | -57.1% |
| Excl P/S+SY+MA200 (25) | +12.5% | 0.87 | -27.7% |
Excluding the most expensive P/S decile adds +1% CAGR (17.1% → 18.1%) with 10 stocks. The MA200 overlay cuts drawdowns dramatically (−57% → −28%) but reduces CAGR. The best risk-adjusted: Excl P/S+SY+MA200 (25 stocks): Sharpe 0.87, DD −27.7%.
Momentum shows the opposite seasonality to value. Value works best in January (tax-loss selling recovery). Momentum works best in September–November — the strongest months for trend continuation before year-end.
Shorter lookback captures more recent trends. With monthly rebalancing, you can act on the latest 6 months of price action. The 12-month variants are better with annual rebalance where stale data matters less.
Below $1B, momentum is noise. Above $5B, it captures real institutional flows and earnings-driven price appreciation.
When the S&P 500 is below its 200-day moving average, go to cash. This avoids the worst momentum crashes (2008, 2020 March) and cuts max drawdown by 20–30 percentage points. Cost: ~1–2% CAGR and 53 months in cash over 20 years.
Removing the most expensive stocks by P/S eliminates the most speculative momentum names. Combined with MA200, this produces a Sharpe ratio of 0.87 — the best risk-adjusted return we found in any strategy.
10 stocks: +17–18% CAGR but −57% max drawdown. 25 stocks: +13% CAGR but manageable volatility. Choose based on your risk tolerance.